PFC Capital Group’s AbbVie ABBV Stock Holding History

PFC Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$335K	Sell	1,335 -225	-14%	-$48.4K	0.13%	70
2026 Q1	$339K	Sell	1,560 -100	-6%	-$22.2K	0.15%	71
2025 Q4	$379K	Hold	1,660	–	–	0.16%	70
2025 Q3	$384K	Buy	+1,660	New	+$338K	0.16%	70
2025 Q2	–	Sell	-1,060	Closed	-$222K	–	83
2025 Q1	$222K	Buy	+1,060	New	+$206K	0.11%	81
2024 Q4	–	Sell	-1,110	Closed	-$219K	–	67
2024 Q3	$219K	Buy	+1,110	New	+$207K	0.11%	65
2024 Q2	–	Sell	-1,110	Closed	-$202K	–	69
2024 Q1	$202K	Buy	+1,110	New	+$191K	0.11%	64

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFC Capital Group's ABBV Position: Q2 2026 in Review

PFC Capital Group reduced its AbbVie (ABBV) stake by 14% in Q2 2026, selling an estimated $48.4K and leaving 1,335 shares worth $335K. The position accounts for 0.13% of the portfolio, ranked #70.

PFC Capital Group first reported a position in ABBV in Q1 2024 and has held it in 7 quarters since. The position peaked at $384K in Q3 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

PFC Capital Group held 1,335 shares of AbbVie worth $335K as of Q2 2026.
PFC Capital Group sold 225 AbbVie shares in Q2 2026, an estimated $48.4K.
AbbVie made up 0.13% of PFC Capital Group's portfolio in Q2 2026, its #70 holding.
PFC Capital Group first reported a position in AbbVie in Q1 2024 and has held it in 7 quarters since.
PFC Capital Group's AbbVie position peaked at $384K in Q3 2025.
4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PFC Capital Group's 13F filing for Q2 2026, filed 6 Aug 2026.